OakChart

Work Medical Technology Group Ltd

WOKHealthcare·Medical Devices·China·Nano·NASD·Nov 11 • 4:00 PM ET

1.37+0.21 (18.10%)
2026-11-12 00:06 CET
Market cap
5.18 USD m
Revenue, TTM
10.72 USD m
Net income, TTM
-4.50 USD m
Free cash flow, TTM
-5.62 USD m
EPS diluted, TTM
-10,677.76
P/E
-
Compare

Price

WOK against its 20, 50 and 200-day averages
2050200
0.0050,000.00100,000.00150,000.007.0M13.9MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26WOKclose 1.3720-day 1.1250-day 1.52200-day 55.131.3752w high

100.0% under the 52-week high of 83,600.00 on 1 Dec 2025. 52-week low 0.91 on 9 Nov 2026. Last 15 sessions, 64.8% high to low

Volume 0.79× normal · the line is the 50-bar volume average

Profile

WOK
52-week range, 0% of the way up
0.9183,600

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Employees238
IPOAug 23, 2024
Beta1.65
ATR, 14d0.15
Rel volume0.79
Short float3.12%
Insider own1.14%
Inst own0.83%

Snapshot

6 groups

Valuation

Index-
Market Cap6.12M
Enterprise Value11.84M
Income-4.50M
Sales10.72M
Book/sh1747.09
Cash/sh0.73
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees238
IPOAug 23, 2024

Ratios

P/E-
Forward P/E-
PEG-
P/S0.57
P/B0.00
P/C1.88
P/FCF-
EV/EBITDA-
EV/Sales1.10
Quick Ratio0.82
Current Ratio1.37
Debt/Eq0.22
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-10677.76
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-20.65% -28.45%
EPS Y/Y TTM-
Sales Y/Y TTM-
EPS Q/Q-179.10%
Sales Q/Q19.13%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own1.14%
Insider Trans-
Inst Own0.83%
Inst Trans3.48%
ROA-10.83%
ROE-20.87%
ROIC-14.92%
Gross Margin12.25%
Oper. Margin-41.68%
Profit Margin-41.95%
SMA2021.80%
SMA50-9.99%
SMA200-97.52%
Trades-

Technical

Shs Outstand4.47M
Shs Float4.42M
Short Float3.12%
Short Ratio0.65
Short Interest0.14M
52W High83600.00 -100.00%
52W Low0.91 50.50%
Volatility20.73% 10.79%
ATR (14)0.15
RSI (14)54.14
Beta1.65
Rel Volume0.79
Avg Volume212.23K
Volume167,423

Performance

Perf Week31.73%
Perf Month-1.44%
Perf Quarter-34.45%
Perf Half Y-99.50%
Perf YTD-99.37%
Perf Year-100.00%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom-
Target Price-
Prev Close1.16
Price1.37
Change %18.10%

Peers

Mkt cap
TickerCompanyMkt cap
BDMDBaird Medical Investment Holdings Limited3.32M
RVPRetractable Technologies Inc16.60M
ICCMIcecure Medical Ltd2.55M
ZJYLJin Medical International Ltd776.74M
UTMDUtah Medical Products Inc208.06M
CUPRCuprina Holdings (Cayman) Ltd10.13M
EMBCEmbecta Corp369.99M
ITOCiTonic Holdings Ltd15.72M
NXGLNexgel Inc13.03M
CPHIChina Pharma Holdings Inc23.37M

Insider trading

latest 14 of 15
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
HRT FINANCIAL LP10% OwnerJun 17 '26Buy0.05880,45640,5011,271,912Jun 23 06:13 PM
HRT FINANCIAL LP10% OwnerJun 18 '26Sale3.87136,665528,894123,944Jun 23 06:13 PM
HRT FINANCIAL LP10% OwnerJun 15 '26Buy0.10268,92725,5483,296,023Jun 17 04:18 PM
HRT FINANCIAL LP10% OwnerJun 16 '26Sale0.062,904,567168,465391,456Jun 17 04:18 PM
HRT FINANCIAL LP10% OwnerJun 12 '26Buy0.0848,1083,8493,027,096Jun 16 09:41 AM
HRT FINANCIAL LP10% OwnerJun 11 '26Buy0.092,029,327188,7272,978,988Jun 12 03:58 PM
HRT FINANCIAL LP10% OwnerJun 10 '26Buy0.101,765,384174,773949,661Jun 12 03:58 PM
HRT FINANCIAL LP10% OwnerJun 09 '26Sale0.103,463,022363,6170Jun 10 03:55 PM
HRT FINANCIAL LP10% OwnerJun 08 '26Buy0.112,261,118239,6792,647,299Jun 09 03:57 PM
HRT FINANCIAL LP10% OwnerJun 04 '26Buy0.101,370,008143,851331,652Jun 08 05:16 PM
HRT FINANCIAL LP10% OwnerJun 05 '26Buy0.0954,5295,071386,181Jun 08 05:16 PM
HRT FINANCIAL LP10% OwnerJun 01 '26Buy0.142,746,332378,994351,959Jun 03 02:34 PM
HRT FINANCIAL LP10% OwnerJun 02 '26Sale0.111,757,955188,1010Jun 03 02:34 PM
HRT FINANCIAL LP10% OwnerMay 28 '26Buy0.091,535,850138,226225,234Jun 01 05:02 PM

News

latest 14 of 70
  • WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026 (GlobeNewswire) -40.84%
  • WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference (GlobeNewswire) -15.70%
  • WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy (GlobeNewswire)
  • BC-Most Active Stocks (Associated Press) -49.23%
  • BC-Most Active Stocks (Associated Press) -58.56%
  • BC-Most Active Stocks (Associated Press) +69.90%
  • AI Healthcare and BioToken Partnership Expands WORK Medicals (WOK) Digital Asset Ambitions (InvestorsHub) +206.25%
  • BC-Most Active Stocks (Associated Press)
  • WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model (GlobeNewswire)
  • WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper (GlobeNewswire) +6.61%
  • WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 (GlobeNewswire) +24.00%
  • WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer (GlobeNewswire)
  • WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 (GlobeNewswire) -32.92%
  • WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation (GlobeNewswire) +11.28%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual47330242280351804560-142010-37010
Period202020212022202320242025
EPS, quarterly
Period
Sales, annual52.52645.86319.71113.56611.5069.849
Period202020212022202320242025
Sales, quarterly
Period
Shares, annual000000
Period202020212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue10.729.8511.5113.5719.7145.8652.53
Cost of Goods Sold Incl. D&A9.407.508.649.4215.2937.2241.68
Gross Profit1.312.342.874.144.428.6410.85
Selling, General and Administrative Excl. Other5.784.846.913.733.784.674.96
Research and Development0.280.440.300.300.180.190.80
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-4.47-2.50-4.050.410.643.975.88
Interest Expense0.330.500.560.370.350.330.26
Unusual Expense0.000.000.000.000.000.004.48
Net Income Before Taxes-4.47-1.08-3.670.111.117.341.33
Income Taxes0.210.12-0.130.050.171.080.11
Consolidated Net Income-4.63-1.20-3.540.060.946.271.22
Net Income From Continuing Operations-4.50-1.07-3.490.110.875.961.16
Net Income-4.50-1.07-3.490.110.875.961.16
EPS (Recurring)-260.72-37,009.87-142,010.684,555.5635,182.67242,281.98174,938.07
EPS (Basic, Before Extraordinaries)-10,677.76-37,010.00-142,010.004,560.0035,180.00242,280.0047,330.00
EPS (Diluted)-10,677.76-37,010.00-142,010.004,560.0035,180.00242,280.0047,330.00
EBITDA-3.37-1.58-2.651.973.908.169.04
Non-Operating Income (Expense)0.331.920.940.070.833.710.19
Other After Tax Adjustments0.000.000.000.000.000.000.00
Price To Sales Ratio0.190.2210.99----
Gross Margin12.2523.8124.9330.5422.4218.8420.65
Operating Margin-41.68-25.34-35.163.043.248.6511.20
Net Margin-41.95-10.89-30.350.834.3912.992.22
Shares Outstanding0.020.000.000.000.000.000.00
Market Capitalization5.185.1874,531,450.0080,040,000.00---

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S1
Total Revenue5.415.314.54
Cost of Goods Sold Incl. D&A4.884.522.98
Gross Profit0.530.781.56
Selling, General and Administrative Excl. Other4.071.713.13
Research and Development0.100.180.25
Other Operating Expense0.000.000.00
Operating Income-3.54-0.93-1.57
Interest Expense0.120.220.29
Unusual Expense0.000.000.00
Net Income Before Taxes-3.51-0.96-0.12
Income Taxes-0.000.21-0.09
Consolidated Net Income-3.46-1.17-0.03
Net Income From Continuing Operations-3.41-1.090.01
Net Income-3.41-1.090.01
EPS (Recurring)-197.76-10,481.80245.06
EPS (Basic, Before Extraordinaries)-197.76-10,480.00250.00
EPS (Diluted)-197.76-10,480.00250.00
EBITDA-3.03-0.34-1.23
Non-Operating Income (Expense)0.140.191.73
Price To Sales Ratio0.190.79-
Gross Margin9.8014.7534.38
Operating Margin-65.35-17.52-34.47
Net Margin-63.01-20.470.29
Shares Outstanding0.020.000.00
Market Capitalization5.184,590,763.318,315,923.81

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments4.096.961.640.770.870.20
Short Term Receivables12.455.7510.996.156.5713.21
Inventories3.687.888.099.0510.6825.37
Other Current Assets0.230.230.080.020.021.59
Total Current Assets20.4620.8320.8015.9918.1540.37
Net Property, Plant & Equipment10.6111.376.747.9811.4514.79
Total Investments and Advances0.000.000.000.000.000.00
Long-Term Note Receivable0.010.010.010.010.050.05
Intangible Assets0.961.041.000.951.061.04
Deferred Tax Assets0.000.250.570.600.540.26
Other Assets1.132.891.360.620.000.00
Total Assets33.1636.4030.4726.1531.2456.51
Short Term Debt Incl. Current Port. of LT Debt6.4114.549.055.996.603.46
Accounts Payable1.721.503.963.209.0411.40
Income Tax Payable0.500.510.740.620.540.00
Other Current Liabilities3.333.635.174.442.7434.70
Total Current Liabilities11.9720.1818.9214.2618.9149.57
Long Term Debt0.020.000.050.070.000.59
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.000.140.510.630.880.37
Other Liabilities0.000.000.000.000.000.00
Total Liabilities11.9920.3219.4814.9519.8050.53
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity18.3513.199.8810.0110.094.95
Total Shareholders Equity18.3513.199.8810.0110.094.95
Accumulated Minority Interest2.832.881.111.191.351.03
Total Equity21.1716.0810.9911.2011.445.98
Total Liabilities & Stockholders Equity33.1636.4030.4726.1531.2456.51
Book Value Per Share177,092.05536,443.03401,859.32406,922.76410,298.06201,309.15
Tangible Book Value Per Share167,833.38493,987.62361,258.65368,294.08367,222.43158,914.75
Full-Time Employees238229216278214300
Price to Book Ratio0.00-----
Return on Assets-3.08-10.450.403.0213.58-
Return on Equity-6.80-30.271.138.6179.23-
Return on Invested Capital-5.84-26.471.138.5959.0521.01
Quick Ratio1.400.640.670.490.390.30
Current Ratio1.711.031.101.120.960.81

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income--1.20-3.540.060.946.271.22
Depreciation-0.921.391.563.264.193.16
Other Funds (Non Cash)--0.030.07-1.140.980.644.58
Funds from Operations--0.20-2.120.394.8710.989.07
Extraordinary Item-0.000.000.000.000.000.00
Changes in Working Capital-6.44-0.110.46-7.13-18.1618.13
Income Taxes Payable-0.00-0.250.140.080.890.00
Cash from Operating Activities-0.876.24-2.230.85-2.26-7.1827.20
Capital Expenditures-4.76-1.33-9.26-0.58-2.01-0.06-17.55
Net Assets From Acquisitions-0.09-0.090.000.000.000.000.00
Sale of Fixed Assets and Businesses0.010.470.190.000.670.000.71
Purchase or Sale of Investments0.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.00
Other Uses-20.10-17.890.000.000.000.000.00
Other Sources11.0511.230.000.000.000.000.00
Cash from Investing Activities-13.89-7.61-9.06-0.58-1.35-0.06-16.84
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock24.506.907.370.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock24.506.907.370.000.000.000.00
Proceedsfrom Stock Options24.506.907.370.000.000.000.00
Issuance or Reduction of Debt, Net-2.66-6.170.44-5.26-9.69-3.01-14.10
Change in Long Term Debt4.010.48-3.59-8.37-9.69-6.39-15.02
Issuance of Long Term Debt-1.550.482.120.020.836.540.00
Reduction of Long Term Debt5.560.00-5.71-8.39-10.52-12.93-15.02
Net Financing Active Other Cash Flow-5.43-1.637.845.8913.2611.003.81
Other Financing Activities Uses-5.83-2.03-0.40----
Cash from Financing Activities16.41-0.9015.660.633.577.99-10.28
Exchange Rate Effect-0.40-0.210.56-0.03-0.06-0.08-0.13
Net Change in Cash1.26-2.474.920.86-0.100.67-0.05
Free Cash Flow-5.624.91-11.450.40-4.27-7.249.65
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Price to Free Cash Flow-0.44-----
Deferred Taxes & Investment Tax Credit-0.11-0.05-0.09-0.31-0.120.11

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S1
Cash & Short Term Investments3.254.092.40
Short Term Receivables5.1112.457.11
Inventories8.593.6811.83
Other Current Assets4.630.230.24
Total Current Assets21.5920.4621.58
Net Property, Plant & Equipment16.7010.6110.85
Total Investments and Advances8.150.000.00
Intangible Assets0.950.960.98
Deferred Tax Assets-0.000.23
Other Assets0.911.131.10
Total Assets48.3233.1634.75
Short Term Debt Incl. Current Port. of LT Debt6.616.4113.03
Accounts Payable1.641.721.47
Income Tax Payable0.520.500.50
Other Current Liabilities7.053.333.98
Total Current Liabilities15.8211.9718.98
Long Term Debt0.010.020.02
Deferred Tax Liabilities0.000.000.03
Other Liabilities0.000.000.00
Total Liabilities15.8311.9919.02
Non-Equity Reserves0.000.000.00
Preferred Stock - Carrying Value0.000.000.00
Common Equity30.1318.3512.95
Total Shareholders Equity30.1318.3512.95
Accumulated Minority Interest2.352.832.77
Total Equity32.4821.1715.72
Total Liabilities & Stockholders Equity48.3233.1634.75
Book Value Per Share1,747.09177,092.05241,294.85
Tangible Book Value Per Share1,691.79167,833.38223,121.63
Price to Book Ratio0.00310,414.85-
Return on Assets-10.83--
Return on Equity-20.87--
Return on Invested Capital-11.31-5.910.10
Quick Ratio0.821.400.51
Current Ratio1.371.711.14

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S1
Extraordinary Item-0.000.00
Cash from Operating Activities-9.919.04-2.80
Capital Expenditures-3.66-1.09-0.24
Net Assets From Acquisitions0.00-0.090.00
Sale of Fixed Assets and Businesses0.000.010.47
Purchase or Sale of Investments0.000.000.00
Purchase of Investments0.000.000.00
Sale Or Maturity of Investments0.000.000.00
Other Uses-3.20-16.91-0.98
Other Sources2.348.712.52
Cash from Investing Activities-4.52-9.371.76
Cash Dividends Paid0.000.000.00
Preferred Dividends (Cash Flow)0.000.000.00
Change in Capital Stock17.606.900.00
Repurchase of Common Pref Stock0.000.000.00
Sale of Common Pref Stock17.606.900.00
Proceedsfrom Stock Options17.606.900.00
Issuance or Reduction of Debt, Net-0.01-2.64-3.53
Change in Long Term Debt0.004.01-3.53
Issuance of Long Term Debt0.00-1.552.04
Reduction of Long Term Debt0.005.56-5.56
Net Financing Active Other Cash Flow-3.80-1.630.00
Other Financing Activities Uses-3.80-2.030.00
Cash from Financing Activities13.782.63-3.53
Exchange Rate Effect-0.19-0.21-0.00
Net Change in Cash-0.842.09-4.56
Free Cash Flow-13.577.95-3.04
Price to Free Cash Flow-1.58-

Revenue breakdown

Commodity Trading2024: 435.73K 2025: 55.41K
Masks2024: 1.56M 2025: 640.43K
Medical Devices Other Than Masks2024: 9.41M 2025: 9.13M
Others Revenue Product2024: 96.21K 2025: 18.50K
New Zealand2024: 11.51M 2025: 9.85M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.12%0.1M4.4M196.07K
2026-10-153.15%0.1M4.4M215.72K
2026-09-303.10%0.1M4.4M537.65K
2026-09-153.09%0.1M4.4M781.59K
2026-08-313.30%0.1M4.4M1.03M
2026-08-148.08%0.2M2.4M1.15M
2026-07-318.69%0.2M2.4M1.14M
2026-07-1512.46%0.3M2.4M1.13M
2026-06-302.17%0.1M2.4M780.36K
2026-06-15-0.0M-528.79K
2026-05-2913.26%0.0M0.0M261.72K
2026-05-1537.90%0.0M0.0M93.45K
2026-04-305.41%0.0M0.0M998
2026-04-156.01%0.0M0.0M1.20K
2026-03-316.86%0.0M0.0M2.50K
2026-03-136.92%0.0M0.0M7.11K
2026-02-277.46%0.0M0.0M7.65K
2026-02-139.92%0.0M0.0M7.60K
2026-01-307.66%0.0M0.0M6.85K
2026-01-150.16%0.0M0.7M6.53K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-04SEC
2026-08-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-24SEC
2026-08-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-08-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-14SEC
2026-06-234Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-16SCHEDULE 13G/ASEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-123Initial statement of beneficial ownership of securities2026-06-10SEC
2026-06-10SCHEDULE 13G/ASEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-09SCHEDULE 13G/ASEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-08SCHEDULE 13GSEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-083Initial statement of beneficial ownership of securities2026-06-04SEC
2026-06-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-05SEC
2026-06-04SCHEDULE 13GSEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-033Initial statement of beneficial ownership of securities2026-06-01SEC
2026-06-023Initial statement of beneficial ownership of securities2026-03-18SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-06-013Initial statement of beneficial ownership of securities2026-05-28SEC
2026-05-283Initial statement of beneficial ownership of securities2026-03-18SEC
2026-05-283Initial statement of beneficial ownership of securities2026-03-18SEC
2026-05-283Initial statement of beneficial ownership of securities2026-03-18SEC
2026-05-283Initial statement of beneficial ownership of securities2026-03-18SEC
2026-05-283Initial statement of beneficial ownership of securities2026-03-18SEC
2026-05-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-27SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-061.20M91.25M4
2026-05138.23K1261.96K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
UBS Group AG0.78%
StoneX Group Inc.0.33%
Tower Research Capital LLC0.02%
North Star Investment Management Corp.0.00%

Funds

Fund% owned
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. WOK. Cached 15 minutes.

Some panels did not load: ratings.